Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP196307.RAukXJAWoXWCmS5Ng17EqqEXd8Kh3lAWiQSAJGJa2v9hI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP196307.RAukXJAWoXWCmS5Ng17EqqEXd8Kh3lAWiQSAJGJa2v9hI130_assertion type Assertion NP196307.RAukXJAWoXWCmS5Ng17EqqEXd8Kh3lAWiQSAJGJa2v9hI130_head.
- NP196307.RAukXJAWoXWCmS5Ng17EqqEXd8Kh3lAWiQSAJGJa2v9hI130_assertion description "[Moderately immunogenic HPV 16-associated murine tumour cell line mimicking human HPV 16-associated neoplasms TC-1 (MHC class I(+)) and its variants, TC-1/P3C10 and TC-1/A9, with a marked down-regulation of MHC I molecules, were used to examine the effect of local interleukin 12 (IL-12) gene therapy for the treatment of early tumour transplants and minimal residual tumour disease obtained after cytoreductive chemotherapy (CMRTD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP196307.RAukXJAWoXWCmS5Ng17EqqEXd8Kh3lAWiQSAJGJa2v9hI130_provenance.
- NP196307.RAukXJAWoXWCmS5Ng17EqqEXd8Kh3lAWiQSAJGJa2v9hI130_assertion evidence source_evidence_literature NP196307.RAukXJAWoXWCmS5Ng17EqqEXd8Kh3lAWiQSAJGJa2v9hI130_provenance.
- NP196307.RAukXJAWoXWCmS5Ng17EqqEXd8Kh3lAWiQSAJGJa2v9hI130_assertion SIO_000772 16328003 NP196307.RAukXJAWoXWCmS5Ng17EqqEXd8Kh3lAWiQSAJGJa2v9hI130_provenance.
- NP196307.RAukXJAWoXWCmS5Ng17EqqEXd8Kh3lAWiQSAJGJa2v9hI130_assertion wasDerivedFrom befree-20140225 NP196307.RAukXJAWoXWCmS5Ng17EqqEXd8Kh3lAWiQSAJGJa2v9hI130_provenance.
- NP196307.RAukXJAWoXWCmS5Ng17EqqEXd8Kh3lAWiQSAJGJa2v9hI130_assertion wasGeneratedBy ECO_0000203 NP196307.RAukXJAWoXWCmS5Ng17EqqEXd8Kh3lAWiQSAJGJa2v9hI130_provenance.